The world's first deliveries of normal babies after use of flow cytometric separated human sperm cells (MicroSort ® ) for preconception gender selection are reported. Offspring were of the desired female gender in 92.9% of the pregnancies. Most of these pregnancies and births were achieved after simple intrauterine insemination.
Introduction
A reliable method for preconception gender selection of offspring in humans has been sought for many years. Historical approaches, including the search for physical, biochemical, and immunological differences, have produced many methods that attempt X and Y sperm cell separation. Among the more prevalent methods reported are albumin gradients, Percoll ® gradients, Sephadex columns, and a modified swim-up, all subsequently resulting in unconfirmed sperm cell separation after DNA analysis and inconsistent gender reports (Flaherty and Matthews, 1996; Reubinoff and Schenker, 1996) .
Any method for separation of X and Y chromosome-bearing spermatozoa must rely on an identifiable difference between these living cells. The only currently recognizable distinction between living X-and Y-bearing spermatozoa is their total DNA content, owing to the larger size of the X chromosome (Pinkel et al., 1982) . In 1987, Johnson et al. reported flow cytometric separation (FCS) of animal X-and Y-bearing spermatozoa into two enriched populations based on total DNA difference (United States Patent #5, 135, 759) . Subsequently, pregnancies and births have been reported in the rabbit (Johnson et al., 1989) , swine (Johnson, 1991) , ovine (Morrell and Dresser, 1989) , and bovine (Cran et al., 1993 ) species using such flow sorted spermatozoa. Over 400 offspring, all normal, have been born using flow sorting technology, including three successive generations in swine (L.A. Johnson, personal communication) and five successive generations in rabbits (Morrell and Dresser, 1989) . The first successful separation of human X-and Y-bearing sperm cells based on the 2.8% total DNA content difference using FCS was reported by Johnson and ourselves , and has been substantiated by fluorescence in-situ hybridization (FISH) analysis (Vidal et al., 1998) . The efficacy of any preconception sperm separation procedure can be determined on a sample aliquot by using FISH techniques with X and Y chromosome-specific probes to stain individual spermatozoa. Levinson et al. (1995) subsequently reported the first human pregnancy using MicroSort and preimplantation embryo genetic testing for the prevention of X-linked hydrocephalus.
We now describe the first births and clinical trial data from the use of MicroSort followed by intrauterine insemination (IUI), in-vitro fertilization (IVF), or intracytoplasmic sperm injection (ICSI). This report presents results with MicroSort FCS designed to achieve enrichment in X chromosome-bearing spermatozoa (XSort ® ).
Materials and methods
Based on the birth of over 400 normal offspring from four species of animals and negative results of the Ames mutagenicity test (Hazelton Washington, Vienna, VA, USA) for the specific dye and laser, an Institutional Review Board approved trial was established to assess flow cytometric separation of X-and Y-bearing spermatozoa in human subjects.
Subject selection
Individuals entered the trial for prevention of sex-linked disorders in offspring or for family balancing. Family balancing was defined as sorting for the gender found in Ͻ50% of the children in that family. Couples were provided with written information, consent documents, and personal counselling regarding the risks and benefits of MicroSort.
Sperm preparation and staining
Fresh or frozen semen specimens were provided for sorting. Fresh semen specimens were allowed to liquefy at 35°C for 30 min. Frozen specimens were thawed at room temperature in a laminar flow hood for 15 min. Specimens were evaluated for volume, count, motility, progression, viability, and percent abnormal cells using WHO standards (World Health Organization, 1992) . Specimens to be sorted were extended, centrifuged, resuspended, filtered through glass wool to remove debris and non-motile sperm cells (Johann et al., 1989) , and treated with a solution of Hoechst 33342, the vital fluorochrome bisbenzimide (Calbiochem-Behring Corporation, La Jolla, CA, USA) using previously described techniques .
Flow cytometric separation
The specimens were sorted by FCS as previously described . Briefly, spermatozoa were sorted using buffered sheath fluid with either a modified Epics ® 753 (Coulter Corporation, Hialeah, FL, USA) or a modified fluorescence-activated cell sorter (FACS ® Vantage; Becton-Dickinson Immunocytometry Systems, San Jose, CA, USA). Fluorescence emitted from each sperm cell was detected through a 400-nm long pass filter, and the enriched fraction of the sorted sample was collected. The motility and progression of the sorted specimen were evaluated at 35°C under paraffin oil using an inverted microscope with Hoffman optics (Leitz; Bunton Instruments, Rockville, MD, USA).
Fluorescence in-situ hybridization
Approximately 3000 to 10 000 spermatozoa from the enriched sorted fraction were used to determine the proportion of X-and Y-bearing cells by FISH using alpha-satellite DNA probes specific for the X and Y chromosomes. The FISH procedure was a modification (Pieters et al., 1990) of one DNA probe standard protocol (Vysis Inc., Downers Grove, IL, USA). Briefly, the sorted cells were washed two times for 6 min at 1300 g with phosphate-buffered saline (PBS). The pellet was resuspended in 10 µl of PBS and air dried in a 0.5-cm 2 area on a glass slide for 10 min at 40°C. The dried cells were subsequently fixed three times each with 2, 5, and 10 µl of fixative (75% methyl alcohol, 25% acetic acid), respectively. Each slide was washed three times with 40 ml of a 2ϫ concentration of SSC (0.3 M NaCl, 30 mM sodium citrate) (Vysis Inc.) at 37°C and allowed to air dry. The fixed spermatozoa were treated with 50 mM dithiothreitol in 0.1 M TrisHCl (pH 8.0 at room temperature) for 8 to 10 min, washed three times with 2ϫSSC and air dried at room temperature. The treated slides were denatured simultaneously with 1 µl of Vysis Spectrum CEP X orange/Y green probe mixture, 10.5 µl Vysis Spectrum CEP hybridization buffer (Vysis) and 3.5 µl of distilled water at 75°C under a 22ϫ22-mm cover glass for 5 min. Similar analyses could also be performed with X and Y probes from other sources. The sperm DNA and the X and Y probe mixture were hybridized for 30 to 45 min at 42°C. The slides were washed with a 0.4ϫSSC (pH 7.0) at 75°C and counter-stained with DAPI (4Ј,6-diamidino-2-phenylindole). The sperm cells were screened using a 60ϫ objective on a Nikon Optiphot-2 (Nikon Inc., Melville, New York, USA) equipped with a dual band pass fluorescein isothiochyocyanate (FITC)/ rhodamine cube and DAPI filter. The sorted sperm cells were identified first using the DAPI filter then analysed by the FITC/rhodamine filter. Spermatozoa identified with one distinct red spot were classified as haploid X chromosome-bearing cells and those with one distinct green spot as haploid Y chromosome-bearing spermatozoa. A total of 200 spermatozoa was counted for each patient.
Post-sort specimen cryopreservation
Sorted specimens to be frozen were extended with TEST yolk buffer freezing medium (Irvine Scientific, Santa Ana, CA, USA), transferred into 1-ml Nunc cryotubes (Nunc, Kamstrup, Denmark) or into 0.25-ml straws (IMV, Minneapolis, MN, USA) and subsequently frozen in a programmable rate freezer (TS Scientific, Perskie, PA, USA) using liquid nitrogen vapour (Mahadevan and Trounson, 1984) . Frozen sorted specimens were stored at -196°C in liquid phase nitrogen.
Frozen specimens used for IVF or ICSI were thawed at room temperature, centrifuged, and resuspended in Ménézo's B2 (Fertility Technologies Inc., Natick, MA, USA) or Whittingham's T6 (Quinn et al., 1984) medium prior to use.
Results

IVF and ICSI
Spermatozoa sorted for the X-bearing chromosome were used for 27 patients in 33 IVF/ICSI cycles. A total of seven clinical 2368 pregnancies resulted in a 21.2% (7/33) clinical pregnancy rate per initiated cycle.
Intrauterine insemination
Intrauterine insemination was performed after appropriate clinical monitoring in 208 cycles using an average of 130ϫ10 3 total motile sperm cells per insemination in 92 patients with an average age of 33.9 years. The average post-MicroSort FISH analysis for XSort samples was 84.5% X-bearing spermatozoa. Twenty-two clinical pregnancies occurred in these 208 IUI cycles (10.6% pregnancy rate/cycle). This rate was rather similar to that reported for medical donor insemination in 10 796 cycles (8.9% pregnancy rate/cycle) (Johnston et al., 1994) and for donor IUI and gamete intra-Fallopian transfer in 21 760 cycles (11.0% pregnancy rate/cycle) (Human Fertilization and Embryology Authority, 1997) without MicroSort.
Pregnancies and births
A total of 29 clinical pregnancies was achieved with MicroSort XSort followed by IUI, IVF, or ICSI. Nine patients have given birth to 11 normal healthy babies, seven pregnancies resulted in spontaneous miscarriage, there was one ectopic pregnancy, and 12 pregnancies are ongoing. Of the 14 pregnancies with known fetal or birth gender, 13 had only female conceptions (92.9%). A total of 88.2% (15/17 including three sets of twins) of the fetuses was of the female gender.
Discussion
We demonstrate the achievement of a substantial number of pregnancies and deliveries of normal babies after use of MicroSort in humans. Importantly, most of these pregnancies were achieved after simple IUI. In 92.9% of the pregnancies, offspring were solely of the desired female gender. All children born so far have been normal and healthy.
The ability to separate X-and Y-bearing sperm cells provides new opportunities for women who are carriers of X-linked disorders. There are over 350 X-linked diseases in humans, including haemophilia, Duchenne muscular dystrophy, and Xlinked hydrocephalus. In most cases, the X-linked diseases are only expressed in the male offspring of carrier mothers. The use of MicroSort for the enrichment of the X chromosomebearing sperm cells can now allow for the preferential conception of unaffected female offspring. Combining MicroSort with IVF or ICSI and subsequent preimplantation embryo testing represents an even more powerful tool for increasing the number of unaffected female embryos conceived, and reducing or eliminating the transfer of male embryos to the uterus.
Current MicroSort technology provides an average of~85% X-bearing spermatozoa in the enriched sorted sample as determined by FISH analysis. This increase would be expected to make it~five to six times more likely to have a female than a male child (85/15 ϭ 5.7) after an XSort. MicroSort technology now provides couples who desire family balancing with a preconception method to increase substantially the probability of having a daughter.
Several characteristics specific to human sperm cells present unique challenges for FCS compared with domestic animal spermatozoa. Some of the issues that affect FCS include the percentage total DNA difference between X-and Y-bearing spermatozoa, physical shape and morphology, variation in the size of the Y chromosome, heterogeneity of the sperm cells, and the range of individual variability. Human sperm cells present a relatively small average total DNA difference (2.8%) between X-and Y-bearing spermatozoa compared with that of some domestic animals (3.6 to 4.1%). In addition, variation in the amount of human Y heterochromatin can result in the Y chromosome being as much as 50% larger in one individual than another. Human spermatozoa are more oval and have a more highly variable morphology than the relatively paddleshaped bull spermatozoa, and these factors may affect cell orientation in the FCS system. It is not uncommon for the average human sperm ejaculate to contain 30 to 50% abnormal cells by WHO standards, and 85% abnormal cells by Kruger strict criteria evaluation, compared with~5 to 10% abnormal cells in bull semen. Sperm cell morphology and, more specifically, acrosome and membrane integrity may affect dye uniformity and light refraction issues relevant to fluorescence detection. Human spermatozoa also present a comparatively high level of heterogeneity within and between individuals.
Pregnancies after IUI using Ͻ1ϫ10 6 motile sperm cells have been obtained in bovine (Seidel et al.,1996) and human (Trout et al., 1995; Centola, 1997) species. Intrauterine insemination using 200 000 to more than 200ϫ10 6 motile spermatozoa in 1761 cycles has shown no significant differences between the number of sperm cells inseminated and pregnancy rate (Cressman et al., 1996) . Current MicroSort technology results in a reduced number of sperm cells compared with the quantity usually used for medical IUI, but still readily achieves many pregnancies. This is consistent with the observation that men with Kallman's syndrome, who have greatly reduced sperm counts but functionally normal spermatozoa, readily impregnate their wives through intercourse (Burris et al., 1988) . In the human, pre-sort processing of the semen sample is required to remove undesirable cells and to enhance the number of normal motile cells prior to FACS. Subsequently, a substantial number of cells passing through the flow cytometer are eliminated due to lack of orientation, undetermined fluorescence difference, and other factors. The retrieval rate currently can vary between 0.6% and 1.2% of the sperm cells passing through the cytometer. Sperm samples starting with 50ϫ10 6 or more cells generally result in~100 000 to 300 000 motile cells for IUI. Smaller numbers of spermatozoa can be used, of course, for ICSI or IVF.
Concerns regarding the use of ultraviolet light and Hoechst 33342 (bisbenzimide) for FCS of human sperm cells have been expressed (Ashwood-Smith, 1994; Munné, 1994) and clarified (Johnson and Schulman, 1994) . Bisbenzimide is a non-intercalating non-cytotoxic DNA stain that preferentially binds to triplet adenine and thymine base pairs in the minor groove outside of the double helix, and the binding is reversible at 37°C. Hoechst 33342 absorbs at 358 nm, a substantial distance from the maximum DNA absorption of~260 nm, excites at 367 nm and emits at 461 nm. While some somatic 2369 cells have been found to be sensitive to bisbenzimide staining (Durand and Olive, 1982; Van Zandt and Fry, 1983) , sperm nuclear DNA has undergone changes including compaction and stabilization that is uniquely different from other cell types. Watkins et al. (1996) found no evidence of mutagenicity of human sperm cells stained with Ͻ900 µM bisbenzimide as assessed by polymerase chain reaction analysis of the betaglobin gene. Catt et al. (1997) also reported no increase in the incidence of endogenous DNA nicks in human sperm cells after bisbenzimide staining and ultraviolet exposure during passage through a fluorescence-activated cell sorter. Concerns regarding embryo development in bovine (Cran et al., 1994) and rabbit (McNutt and Johnson, 1996) species were not observed in our experience with humans, which resulted in a 92% embryo cleavage rate (unpublished data) and 21.2% pregnancy rate per transfer cycle. Most importantly, as in the animal data from several species with hundreds of normal births, all offspring born from FCS of human spermatozoa have been normal and healthy.
MicroSort provides a significantly high degree of X-bearing sperm enrichment and represents the only validated method for preferential conception of daughters. MicroSort also achieves Y-chromosome enrichment of sperm populations (YSort ® ), but to a lesser extent than the X-chromosome enrichment from the XSort results reported here; our ongoing trial with YSorts will be subsequently reported.
Fundamental principles of liberty affirm that couples should be free to choose their own reproductive options. The preferential conception of a daughter in couples at risk for transmitting an X-linked disease provides the couple with a higher likelihood of an unaffected child. Furthermore, several surveys have indicated that a majority of couples approve in principle of preconception gender selection for purposes of family balancing (Rosenzweig and Adelman, 1976; Markle and Nam, 1982) . Our experience with couples who actually enquired about gender selection indicates that 53.6% (675/1259) of such enquirers desired female offspring. This slight preference for girls is consistent with other reports by Batzofin (1987) for American couples and Liu and Rose (1995) in the UK. The majority of couples (90.5%) in our study were seeking gender preselection for family balancing purposes, were in their mid thirties, had two or three children of the same sex, and desired only one more child.
In summary, a significant number of individual normal births in humans has been achieved using MicroSort, IUI, and IVF and ICSI. Pregnancies have also been attained with the use of frozen sorted sperm cells. MicroSort technology should find broad application, and continued refinement is expected to provide improvements in both sperm purity and recovery.
